Marrow Transplantation in Children: Current Results and Controversies - Meeting #6

Share article


English

Date: November 8 - 10, 2001
Location: St. Augustine, Florida, USA


Venue: World Golf Village Renaissance Resort

Symposium Web Page: www.pedsref.org

Sponsor: The Alfred I. duPont Hospital for Children of The Nemours Foundation

Who should attend:

Pediatric marrow transplanters, pediatric hematologists/oncologists, nurses involved in both the pediatric marrow transplant area and the pediatric hematology/oncology area and other allied health professionals, such as physician assistants, working in this area.

Topics:

Major subjects include eligibility for transplant studies, long-term complications related to the preparative therapies and the transplant process, choice of donor and what types of donor marrow or stem cells work best in certain situations, and dealing with some of the more significant immediate post-transplant complications particularly focusing on issues of intensive care. A variety of new applications of marrow transplant will also be explored.

Speakers:

Jeffrey M. Lipton, MD, PhD, "Peripheral Blood as a Stem Cell Source in Children: Is the Effort in Vein?"

Chatchada Karanes, MD, "The Impact of Selection of Unrelated Donors on Outcome of Allogeneic Stem Cell Transplant"

Rupert Handgretinger, MD, PhD, "Megadose Transplantation of Highly Purified Haploidentical Stem Cells: Current Results and Future Prospects"

John E. Wagner, Jr., MD, "Umbilical Cord Blood Versus Marrow Stem Cells: That is the Question"

Dana Matthews, MD, "Radiolabeled Antibodies in Children: Can We Use Them? Should We?"

Thomas R. Spitzer, MD, "The Expanding Applications of Non-Myeloablative Stem Cell Transplantation"

Bruce Bostrom, MD, "Busulfan: Formulations and Pharmacokinetics"

Martin Schrappe, MD, PhD, "Identification and Treatment of High-Risk ALL With and Without Stem Cell Transplantation"

James Nachman, MD, "Population Based Study of Impact of Allogeneic BMT on Outcome for Children With ALL in Second Remission"

Howard J. Weinstein, MD, "AML -- The Road to Remission and Marrow Transplant Controversies"

Eva C. Guinan, MD, "Transplant and Tolerance"

Paul A. Carpenter, MD, "Steroid Refractory GvHD: Past, Present and Future"

John R. Wingard, MD, "Advances in Antifungal Therapies"

Susan F. Leitman, MD, "The Role of Granulocyte Transfusions Following Stem Cell Transplantation"

Stephen Chanock, MD, "The Human Genome and Transplantation Outcomes: Challenges and Future Considerations"

Thomas G. Gross, MD, PhD, "EBV PTLD -- Can it be Prevented or Cured?"

Madelyn Kahana, MD, "Novel ICU Care for Pediatric Bone Marrow Transplant Recipients"

Deborah C. Molrine, MD, "Recommendations for Immunizations in Stem Cell Transplantation"

Ronald Barr, MD, "Costs and Consequences of Stem Cell Transplants in Children"

Charles Peterson, MD, MBA, "Blood and Marrow Transplant Clinical Research network"

Norman C. Fost, MD, MPH, "Conception for Donation: What's Wrong with Engineering Donors?"

Phyllis I. Warkentin, MD, "Hematopoietic Stem Cell Transplants: Regulation and Accreditation"

Edwin Horwitz, MD, PhD, "Bone Marrow Transplantation: It's Not Just About Blood Anymore"

Leonard Mattano, MD, "The Skeletal Remains: Porosis & Necrosis of Bone in the Marrow Transplantation Setting"

Donald Orlic, PhD, "Bone Marrow Stem Cells Regenerate Infarcted Myocardium"


Continuing Education: 17.75 CME in Category 1

Fees:

  • $450 Before August 1, 2001 (Physicians)
  • $500 After August 1, 2001 (Physicians)
  • $250 Nurses and Physician Assistants
  • $150 Physicians-in-training and other allied health personnel-in-training

English
News
Also, double unrelated cord blood transplant tied to better outcomes in leukemia patients

Dec 8, 2010 - Individuals who donate peripheral blood stem cells or bone marrow do not appear to be at an overall increased risk of cancer, according to research being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. According to another study, acute myeloid or lymphoblastic leukemia patients who receive double unrelated cord blood transplants may experience better overall outcomes than those who receive single cord blood transplants. Other studies being presented address stem cell transplant procedures in treating various hematologic malignancies and highlight zoledronic acid's ability to improve survival in multiple myeloma patients.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información